Sign Up to like & get
recommendations!
1
Published in 2022 at "Osteoporosis International"
DOI: 10.1007/s00198-021-06268-9
Abstract: This paper systematically reviewed and assessed all retrievable pharmacoeconomic studies on denosumab for the treatment of osteoporosis. Denosumab was more cost-effective in patients with older age, prior fracture experience, lower BMD T-scores, and more risk…
read more here.
Keywords:
pharmacoeconomic studies;
denosumab osteoporosis;
cost;
osteoporosis ... See more keywords